Marvell Technology posted a record Q2 revenue of $2.74 billion, driven by broad growth in data center products and customers. The company raised its revenue guidance for fiscal years 2027 and 2028, supported by strong demand for AI connectivity, custom silicon, optics, and CXL memory products. Despite risks from lower gross margins, customer concentration, warrant dilution, and capacity commitments, Marvell's robust free cash flow and expanding product opportunities underpin a strong long-term investment case. The analyst maintains a Strong Buy rating with a $375.28 price target based on improving operating leverage and growth prospects.
Marvel Biosciences Corp. has received approval from the TSX Venture Exchange to extend the closing deadline for its private placement from August 31 to September 14, 2026. The company, which develops synthetic chemical derivatives of off-patent drugs...
Marvell Technology has delivered a 242% gain over the past year and is expected to continue growing due to accelerating AI infrastructure spending and custom silicon revenue set to more than double in fiscal 2028. The company reported strong Q2 fisca...
Marvell Technology and Broadcom both reported strong AI-driven revenue growth, but at vastly different scales. Broadcom's AI chip revenue hit $16.7 billion, part of its $29.6 billion total, while Marvell's entire business was $2.7 billion. Marvell fo...
Marvell Technology's CEO Matt Murphy attributes the company's 241% stock rise over the past year to a decade-long build of trust with major tech firms. This trust has enabled Marvell to secure significant AI ecosystem partnerships, including deals wi...
Marvell's stock erased most gains following Nvidia CEO Jensen Huang's positive remarks about the company. Finbold's AI analysis predicts a mixed outlook for Marvell, with price targets ranging from a 7.74% drop to a 5.48% rise by September 30, 2026. ...
